āshibio Emerges from Stealth with $40M to Advance Novel Therapies for Rare Genetic Diseases
A California-based biotechnology company, āshibio, Inc, has emerged from stealth with a combined seed and series A funding of $40M to accelerate the development of novel therapies for connective tissues and bone disorders.
Founded in 2021 by Chief Executive Officer Pankaj Bhargava, the startup’s latest round was spearheaded by MPM BioImpact, with participation from Agent Capital, Mirae Asset Venture Inv... moreāshibio Emerges from Stealth with $40M to Advance Novel Therapies for Rare Genetic Diseases
A California-based biotechnology company, āshibio, Inc, has emerged from stealth with a combined seed and series A funding of $40M to accelerate the development of novel therapies for connective tissues and bone disorders.
Founded in 2021 by Chief Executive Officer Pankaj Bhargava, the startup’s latest round was spearheaded by MPM BioImpact, with participation from Agent Capital, Mirae Asset Venture Investments (India), and YK Bioventures.
